Michelle Fraser

Michelle Fraser

Company: Revvity

Job title: Head of Cell and Gene Therapy


Next Generation Evolved and VHH- Modified AAV Vectors for Retinal Gene Transfer and Local Gene Delivery 11:00 am

Analyzing the transduction of multiplexed vectors for retinal gene transfer, following subretinal dosing at the single-cell level Exploring Revvity’s novel direct-targeted AAV vector platform, developed by inserting a VHH domain into the cap protein Optimizing production to generate yields of 1.4E14vg/l in suspension cells and enhanced in vitro and in vivo gene delivery Showcasing promising…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.